全球核酸檢驗市場:對試劑業者而言的新產品開發機會及商務擴大策略 是由出版商Venture Planning Group在2011年06月所出版的。
這份英文市場調查報告書包含1050 Pages 價格從美金28500起跳。
核酸檢驗市場是體外診斷業界成長最快的領域之一，今後十年因試劑系統自動化、被視為必要的創新營銷方法及新產品的導入等等，預計將會有重大的變化。但是定斯臨床檢查的市場滲透率，仍決定於是否導入費用與效果相對皆高的自動化系統上。
本報告提供全球7大市場的核酸檢驗市場趨勢及技術趨勢，今後5年及10年的檢驗件數與銷售額預測，主要競爭企業的市場佔有率和簡介等資料，為您概述為以下內容。
介紹
全球市場和技術概要
- DNA定序
- DNA以及RNA探針技術
- 檢測技術
- 設備評估
- 生物晶片：基因感應器・微陣列・微縮晶片實驗室
- 藥理基因體學
- 主要的應用
- 微生物學・感染疾病
- 癌症檢查
- 遺傳基因疾病
- 刑事鑑定
- 親子鑑定/組織相容抗原檢查
- 成本分析
- 競爭及技術互補
- 報銷問題
- 全球市場分析
法國
- 摘要整理
- 商務環境
- 市場構造
- 市場規模，成長，主要業者的銷售額和市場佔有率
德國
義大利
日本
西班牙
英國
美國
主要產品開發機會
- 設備
- 試劑包及檢驗系統
- 電腦，軟體，自動化
- 補助產品
分散檢驗產品的設計基準
替代市場滲透策略
- 公司內部開發
- 合作契約
- 跟大學的合作
- 流通策略
- 營銷方法
- 產品的複雜性
- 顧客的喜好
- 傳統供應商
- 新興供應商
- 銷售商的種類
- 市場區隔
打入市場的障壁及風險
- 市場成熟度
- 成本控制
- 競爭
- 技術力和限制
- 專利的保護
- 相關法律的規定
- 市場的課題
競爭簡介
附錄
Abstract
This comprehensive seven-country report is designed to help current suppliers
and potential market entrants identify and evaluate major business
opportunities emerging in the NAT market during this decade.
Highlights
- Business and technological trends in seven major markets
- Five - and ten-year test volume and sales forecasts
- Market shares of leading competitors
- Feature comparison of major analyzers
- Profiles of market players and start-up firms developing innovative
technologies and products
- Specific product and business opportunities for instrument and consumable
suppliers.
Rationale
The NAT market is unquestionably the most rapidly growing segment of the in
vitro diagnostics industry. The next ten years will witness significant
developments in reagent systems and automation, as well as introduction of a
wide range of new products that will require innovative marketing approaches.
The rate of market penetration into routine clinical laboratories, however,
will depend on the introduction of cost-effective and automated systems with
amplification methods.
In order to successfully capitalize on the opportunities presented by the NAT
market, many companies are already exploiting new molecular technologies as
corporate strategic assets, managed in support of business and marketing
strategies. Integrating new technology planning with business and corporate
strategies will be one of the most challenging tasks for diagnostic companies
during the next ten years.
Geographic Coverage
- France
- Germany
- Italy
- Japan
- Spain
- UK
- USA
Worldwide Market Overview
- Laboratories performing DNA sequencing and NATby country and market
segment.
- Ten-year test volume and sales projections by country.
Market Segmentation Analysis
- Sales and market shares of major suppliers of NAT reagent kits and
components.
- Ten-year test volume and sales forecasts for major applications, including:
- Infectious Diseases
- Cancer
- Genetic Diseases
- Forensic Testing
- Paternity Testing/HLA Typing
- Others
- Ten-year test volume and sales projections for over 30 NAT assays.
- A comprehensive analysis of the sequencing market, by country and
laboratory segment, including:
- Detailed market segmentation analysis, including review of the market
dynamics, trends, structure, size, growth and major suppliers, by country.
Product/Technology Review
- Comparison of leading NAT analyzers from Abbott, Beckman Coulter, BD,
Bio-Rad, Gen-Probe, Roche, Tecan and other suppliers.
- Extensive review of NAT technologies, test formats, detection
methodologies, trends in testing automation and over 30 target/signal
amplification methods, including:
- PCR
- SDA
- TMA
- LCR
- bDNA
- NASBA
- SSSR, and others
- Worldwide listings of companies, universities and research centers
developing new NAT technologies and products.
Competitive Assessments
- Extensive strategic assessments of major suppliers and emerging market
entrants, including their sales, product portfolios, marketing tactics,
collaborative arrangements and new technologies/products in R&D.
- Comprehensive listings of companies developing and marketing NAT products,
by test and application.
Opportunities and Strategic Recommendations
- Specific new product development opportunities with potentially
significant market appeal during the next ten years.
- Design criteria for new products.
- Alternative market penetration strategies.
- Potential market entry barriers and risks.
- Business planning issues and concerns.
Methodology
This report is based on a combination of primary and secondary information
sources, including interviews with laboratory directors and executives of
leading diagnostic companies and start-up firms developing innovative
technologies and products in the U.S., five major European countries and Japan.
In addition to primary sources of information, a comprehensive review of the
most recent technical and business publications, manufacturer product and
financial literature, as well as Venture Planning Group' s proprietary data
base was conducted.
Contains 1050 pages and 96 tables.
Table of Contents
Introduction
Worldwide Market And Technology Overview
- A. DNA Sequencing
- 1. Introduction
- 2. Sequencing Methods
- 3. Autoradiography
- 4. The Human Genome Project
- 5. Sequencing Automation
- 6. Image Scanners
- 7. Fluorescent Detection
- 8. Gene Profiling
- 9. Gene Expression
- 10. Polymorphism Screening
- 11. Protein Interaction Networks
- B. DNA And RNA Probe Technology
- 1. Basic Principles
- 2. Probe Preparation
- 3. The DNA Probe Test
- a. Sample Preparation
- b. Hybridization
- c. Separation
- d. Detection/Measurement
- 4. Test Formats
- a. Filter Hybridization
- b. Southern Blot
- c. Northern Blot
- d. In Situ Hybridization
- e. Others
- 5. Labeling Techniques
- 6. Amplification Methods
- Polymerase Chain Reaction
- Temperature Cyclers
- PCR Variations
- Immuno-PCR
- QC-PCR
- DAP-PCR
- Strand Displacement Activation
- TMA
- Ligase Chain Reaction
- Branched DNA
- Hybridization Protection Assay
- Nucleic-Acid Sequence-Based Amplification
- Self-Sustained Sequence Replicase
- Others
- Ampliprobe
- CAR
- CAS
- CPT
- Dendritic Polymer Technology
- ISO-CR
- LAT
- Probe Networks
- RAMP
- Repair Chain Reaction
- Rolling Circles
- Sequence Independent Gene Amplification
- Sequence Initiation Reaction
- SISPA
- C. Detection Technologies
- 1. Radioactive Methods
- a. Overview
- b. Major Isotopes
- 2. Non-Isotopic Methods
- a. Enzymatic Labels
- b. Chemical Labeling
- Indirect Chemical Labeling
- Direct Chemical Labeling
- c. Fluorescence
- d. Chemiluminescence
- e. Electrical Conductivity
- D. Instrumentation Review
- 1. Abbott LCx
- 2. Autogenomics Infinity
- 3. Beckman Coulter/Biomek FK
- 4. Becton Dickinson SDA
- 5. Bio-Rad GeneScope
- 6. Gen-Probe Tigris
- 7. Nanosphere Verigen Series
- 8. Roche Cobas Amplicor
- 9. Tecan LS Series
- E. Biochips: Genosensors, Microarrays, and Labs-on-the-Chip
- Liquid Transportation and Mixing
- Separation
- Reaction
- Detection
- F. Pharmacogenomics
- G. Major Applications
- 1. Microbiology/Infectious Diseases
- a. Overview
- b. Major Infectious Diseases
- AIDS
- Structure and Composition
- Classification
- AIDS Origins
- Animal Lentivirus Systems
- Virus Receptors
- HIV Infections in Humans
- Pathogenesis and Pathology
- CD4T Lymphocytes and Memory Cells
- Monocytes and Macrophages
- Lymphoid Organs
- Neural Cells
- Viral Coinfections
- Plasma Viral Load
- Pediatric AIDS
- Neurologic Disease
- Opportunistic Infections
- Cancer
- Immunity
- Laboratory Diagnosis
- Virus Isolation
- Serology
- Viral Nucleic Acid/Antigen Detection
- Epidemiology
- Worldwide Spread of AIDS
- United States
- Routes of Transmission
- Prevention, Treatment, And Control
- Transmission HIV in Blood Products
- HIV Transmission in Transplant and Artificial Insemination
Recipients
- Diagnostic Tests
- Enzyme Immunoassay Interpretation
- Specificity, Sensitivity and Predictive Value
- Competition Assays
- Western Blot Technique
- Immuno-Fluorescence Assays (IFA)
- Radioimmunoprecipitation
- HIV-1/HIV-2 Combination Testing
- Methods of HIV-Antigen Detection
- Antigen Assays and Blood Screening
- Urine Tests
- DNA Probes
- Overview
- Quantitative PCR
- In Situ PCR
- Needed Improvements
- Viral Load/Drug Resistance Testing
- Genotype and Phenotype Testing
- Blood Banking Considerations
- Adenovirus
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Adeno-Associated Viruses (AAV)
- Anthrax/Bacillus Anthracis
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Babesiosis
- BEA and Other Bartonella Diseases
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Chagas Disease
- Campylobacter
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Chlamydia
- Background
- Chlamydia psittaci
- Chlmaydia pneumoniae
- Chlamydia trachomatis
- Diagnostic Tests
- Vaccines and Drugs
- Creutzfeldt-Jakob' s Disease
- Background
- Blood Transmission
- Diagnostic Tests
- Major Commercial and Academic Players
- Bayer
- Disease Sciences/Bio Tec Global
- Imperial College School of Medicine
- Ortho-Clinical Diagnostics
- Pall
- ProMetic Life Sciences
- Proteome Sciences/Idexx
- Q-One Biotech
- Serono
- U.S. Agricultural Research Service
- Drugs
- Vaccines
- Cytomegalovirus
- Background
- Chorioretinitis
- Gastrointestinal
- Central Nervous System Disease
- Diagnostic Tests
- Vaccines and Drugs
- Ebola Virus
- Background
- Epidemiology
- Clinical Syndromes
- Diagnostic Tests
- Vaccines and Drugs
- EchoVirus
- Background
- Acute Aseptic Meningitisis
- Encephalitis
- Exanthems
- Respiratory Disease
- Myopericarditis
- Neonatal Infections
- Diagnostic Tests
- Vaccines and Drugs
- Encephalitis
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Enteroviruses
- Background
- Diagnostic Tests
- Viral Isolation and Identification
- Antibody Tests
- Vaccines and Drugs
- Epstein-Barr Virus
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Gonorrhea
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Hepatitis
- Hepatitis A
- Hepatitis B
- Structure and Composition
- Replication
- Hepatitis C
- Hepatitis D (Delta)
- Hepatitis E
- Hepatitis G
- Hepatitis Infections Pathology
- Clinical Findings
- Laboratory Tests
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D
- Hepatitis E
- Virus-Host Immune Reactions
- Epidemiology
- Hepatitis A
- Hepatitis B
- Hepatitis C
- Hepatitis D (Delta)
- Vaccines and Drugs
- Herpes Simplex Virus
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Legionella
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Lyme Disease
- Background
- Clinical Description
- Clinical Case Definition
- Laboratory Criteria for Diagnosis
- Case Classification
- Diagnostic Tests
- Vaccines and Drugs
- Malaria
- Mycoplasma
- Background
- Ureaplasma Urealyticum & Mycoplasma Hominis
- Diagnostic Tests
- Vaccines and Drugs
- Papillomaviruses/HPV
- Background
- HPV in Cancer
- Cervical Neoplasm
- Diagnostic Tests
- Vaccines and Drugs
- Parvovirus B19
- Background
- Microbiology
- Epidemiology
- Clinical Syndromes
- Erythema Infectiosum (Slapped Cheek)
- Adult Polyarthropathy
- Transient Aplastic Crisis
- Transient Pancytopenia
- Red Cell Aplasia in Immunocompromised
- Perinatal Infections
- Diagnostic Test
- Vaccines and Drugs
- Pneumonia
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Polyomaviruses
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Salmonellosis
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Shigellosis
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Streptococci
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Group A Streptococci
- Group B Streptococci
- Toxoplasmosis
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Tuberculosis
- Background
- Diagnostic Tests
- Microscopic Characteristics
- Cultural Characteristics
- Skin Tests
- MDRTB
- Vaccines and Drugs
- West Nile Virus
- Background
- Diagnostic Tests
- Vaccines and Drugs
- Yersinia
- Background
- Diagnostic Tests
- Vaccines and Drugs
- c. Antibiotic Susceptibility
- 2. Cancer Testing
- a. Overview
- b. Major Cancer Types
- Prostate
- Lung
- Colon and Rectum
- Breast
- Skin
- Uterine
- Leukemia
- Oral
- c. Oncogenes
- Abl/abl-bcr
- AIB1
- BRCA1
- CD44
- C-fos
- C-myb
- C-myc
- CYP17
- Erb-B
- HPC1
- N-myc
- P40
- P51
- P53
- PIK3CA
- PTI-1
- Ras
- Reg
- Sis
- Src
- 3. Genetic Diseases
- a. Overview
- b. Nucleic Acid Amplification
- c. Chromosome Imaging
- d. Genomics Technologies
- e. Proteomics Technologies
- f. Current Pharmacogenomic Tests
- g. Future Pharmacogenomic Testing
- h. Major Diseases
- Achondroplasia
- Autosomal Dominant Polycystic Kidney Disease
- Cancer
- Cosmetogenomics
- Cystic Fibrosis
- Down' s Syndrome
- Duchenne and Becker Muscular Dystrophy
- Factor V (Leiden)
- Factor IX Deficiency
- Fragile X Syndrome
- Heart Disease
- Hemochomatosis
- Hemophilia
- Huntington' s Disease
- Maternal-Fetal Incompatibility
- Multiple Endocrine Neoplasia
- Phenylketonuria (PKU)
- Polycystic Kidney Disease (PKD)
- Prenatal Screening
- Retinitis Pigmentosa
- Retinoblastoma
- Sickle Cell Anemia
- Spinal Muscular Atrophy
- Vitamin B12 Metabolism
- i. Social Issues and Concerns
- 4. Forensic Testing
- a. Overview
- b. Multilocus and Single Locus Probes
- Multilocus Probes
- Single Locus Probes
- PCR and RFLP
- c. The FBI
- d. DNA Profile Data Banks
- e. Judicial Implementation
- f. Major Crime Categories
- g. Factors Contributing to the DNA Probe Market Expansion
- Technology Availability
- Use of Hair as Evidence
- h. Wildlife Forensics
- 5. Paternity Testing/HLA Typing
- 6. Other Applications
- a. Disease Susceptibility Testing
- b. Cardiovascular Diseases
- c. Diabetes
- d. Alzheimer' s Disease
- e. Plasma Purification
- f. Organ Transplantation
- g. Water Contamination
- h. Others
- G. Cost Analysis
- 1. Equipment
- 2. Consumables
- H. Competing/complementing Technologies
- 1. Monoclonal Antibodies/Immunoassays
- 2. RNA Probes
- 3. Two-Dimensional Electrophoresis
- 4. Flow Cytometry
- I. Reimbursement Issues
- J. Worldwide Market Overview
- 1. Business Environment
- 2. Market Structure
- 3. Market Size and Growth
France
- A. Executive Summary
- B. Business Environment
- C. Market Structure
- D. Market Size, Growth And Major Suppliers' Sales And Market Shares
Germany
- A. Executive Summary
- B. Business Environment
- C. Market Structure
- D. Market Size, Growth And Major Suppliers' Sales And Market Shares
Italy
- A. Executive Summary
- B. Business Environment
- C. Market Structure
- D. Market Size, Growth And Major Suppliers' Sales And Market Shares
Japan
- A. Executive Summary
- B. Business Environment
- C. Market Structure
- D. Market Size, Growth And Major Suppliers' Sales And Market Shares
Spain
- A. Executive Summary
- B. Business Environment
- C. Market Structure
- D. Market Size, Growth And Major Suppliers' Sales And Market Shares
U.K.
- A. Executive Summary
- B. Business Environment
- C. Market Structure
- D. Market Size, Growth And Major Suppliers' Sales And Market Shares
U.S.A.
- A. Executive Summary
- B. Business Environment
- 1. Health Care Expenditures
- 2. Cost Consciousness
- 3. Reimbursement
- 4. Industry Consolidation
- 5. Managed Care
- 6. Hospitals
- 7. Admissions
- 8. Length of Stay
- 9. Industry Diversification
- 10. Physician Demographics
- 11. Population Aging
- a. Chronic Illness
- b. Disease Incidence
- c. Susceptibility to Iatrogenesis
- d. Multiple Illness Cases
- 12. Laboratory Regulations
- 13. FDA Reform
- C. Market Structure
- 1. Hospitals
- 2. Commercial/Private Laboratories
- 3. Blood Banks
- D. Market Size, Growth and Major Suppliers' Sales and Market Shares
Major Product Development Opportunities
- A. Instrumentation
- B. Reagent Kits and Test Systems/panels
- C. Computers, Software and Automation
- D. Auxiliary Products
Design Criteria For Decentralized Testing Products
Alternative Market Penetration Strategies
- A. Internal Development
- B. Collaborative Arrangements
- C. University Contracts
- D. Distribution Strategies For Decentralized Testing Markets
- 1. Marketing Approaches
- 2. Product Complexity
- 3. Customer Preference
- 4. Established Suppliers
- 5. Emerging Suppliers
- 6. Major Types Of Distributors
- 7. Market Segmentation
Potential Market Entry Barriers And Risks
- A. Market Maturity
- B. Cost Containment
- C. Competition
- D. Technological Edge And Limitations
- E. Patent Protection
- F. Regulatory Constraints
- G. Decentralized Testing Market Challenges
Competitive Profiles
- Abbott
- Aclara
- Affymetrix
- Agilent
- Ambion
- Applera
- Applied Gene Technologies
- Beckman Coulter
- Becton Dickinson
- Biokit
- BioMerieux
- Biotest
- Boston Biomedica
- Caliper
- Cepheid
- Chiron
- Decode
- Diadexus
- Digene
- Eiken
- Enzo
- Exact Sciences
- Fujirebio
- Gen-Probe
- Gene Tec
- Illumina
- Innogenetics
- Kreatech
- Li-Cor
- Molecular Diagnostics
- Myriad Genetics
- Nanogen
- Nuvelo
- Orchid Biosciences
- Qiagen
- Roche
- Sangtec
- Sequenom
- Scienion
- Sierra Diagnostics
- Shimadzu
- Takara Bio
- Tepnel Life Sciences
- Tecan Group
- Third Wave
Appendixes
- Appendix I: Major Companies Developing or Marketing NAT Reagents
and Test Kits
- Appendix II: Major Universities and Research Centers Developing NAT
Technologies
- Appendix III: Glossary of Terms
- Appendix IV: Currency Exchange Rates
List of Tables
- Major Companies Developing or Marketing Thermocyclers
- Major Companies Developing or Marketing AIDS NAT
- And Other Direct Identification Tests
- Major Companies Developing or Marketing Adenovirus
- NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing Campylobacter
- NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing Chlamydia
- NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing CMV NAT
- And Other Direct Identification Tests
- Major Companies Developing or Marketing EBV NAT And Other Direct
Identification Tests
- Major Companies Developing or Marketing Gonorrhea
- NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing Hepatitis
- NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing Herpes
- NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing Legionella
- NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing Lyme
- Disease NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing Mycoplasma
- NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing Papilloma
- Virus NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing Pneumonia
- NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing Salmonella
- NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing Shigella
- NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing Streptococci
- NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing Toxoplasmosis
- NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing Tuberculosis
- NAT And Other Direct Identification Tests
- Major Companies Developing or Marketing Cancer NAT Tests
- Major Companies Developing or Marketing NAT Assays For Genetic Diseases
- Worldwide, Laboratories Performing DNA Sequencing By Country
- Worldwide, NAT Market, Potential Laboratory Universe by Country
- Worldwide, NAT Volume Forecast by Country
- Worldwide, NAT Market Forecast by Country
- Summary Table France, NAT Volume And Sales Forecast by Major Application
- France, Laboratories Performing DNA Sequencing By Market Segment
- France, NAT Market Potential Laboratory Universe by Market Segment
- France, NAT Volume Forecast By Major Application
- France, Major Infectious Disease NAT Volume Forecast
- France, Infectious Disease Screening NAT Volume Forecast
- France, NAT Market Forecast By Major Application
- France, Infectious Disease Screening NAT Reagent Market Forecast by Test
- France, NAT Market By Major Supplier
- France, HIV/Hepatitis NAT Market By Major Supplier
- Summary Table Germany, NAT Volume And Sales Forecast by Major Application
- Germany, Laboratories Performing DNA Sequencing by Market Segment
- Germany, NAT Market Potential Laboratory Universe By Market Segment
- Germany, NAT Volume Forecast By Major Application
- Germany, Major Infectious Disease NAT Volume Forecast
- Germany, Infectious Disease Screening NAT Volume Forecast
- Germany, NAT Market Forecast By Major Application
- Germany, Infectious Disease Screening NAT Reagent Market Forecast by Test
- Germany, NAT Market by Major Supplier
- Germany, HIV/Hepatitis NAT Market by Major Supplier
- Summary Table Italy, NAT Volume And Sales Forecast by Major Application
- Italy, Laboratories Performing DNA Sequencing by Market Segment
- Italy, NAT Market Potential Laboratory Universe by Market Segment
- Italy, NAT Volume Forecast By Major Application
- Italy, Major Infectious Disease NAT Volume Forecast
- Italy, Infectious Disease Screening NAT Volume Forecast
- Italy, NAT Market Forecast By Major Application
- Italy, Infectious Disease Screening NAT Reagent Market Forecast by Test
- Italy, NAT Market By Major Supplier
- Italy, HIV/Hepatitis NAT Market By Major Supplier
- Summary Table Japan, NAT Volume And Sales Forecast by Major Application
- Japan, Laboratories Performing DNA Sequencing by Market Segment
- Japan, NAT Market Potential Laboratory Universe by Market Segment
- Japan, NAT Volume Forecast By Major Application
- Japan, Major Infectious Disease NAT Volume Forecast
- Japan, Infectious Disease Screening NAT Volume Forecast
- Japan, NAT Market Forecast By Major Application
- Japan, Infectious Disease Screening NAT Market Forecast by Test
- Japan, NAT Market By Major Supplier
- Japan, HIV/Hepatitis NAT Market by Major Supplier
- Summary Table Spain, NAT Volume And Sales Forecast by Major Application
- Spain, Laboratories Performing DNA Sequencing by Market Segment
- Spain, NAT Market, Potential Laboratory Universe by Market Segment
- Spain, NAT Volume Forecast by Major Application
- Spain, Major Infectious Disease NAT Volume Forecast
- Spain, Infectious Disease Screening NAT Volume Forecast
- Spain, NAT Market Forecast By Major Application
- Spain, Infectious Disease Screening NAT Reagent Market Forecast by Test
- Spain, NAT Market By Major Supplier
- Spain, HIV/Hepatitis NAT Market by Major Supplier
- Summary Table U.K., NAT Volume And Sales Forecast by Major Application
- U.K., Laboratories Performing DNA Sequencing by Market Segment
- U.K., NAT Market Potential Laboratory Universe by Market Segment
- U.K., NAT Volume Forecast By Major Application
- U.K., Major Infectious Disease NAT Volume Forecast
- U.K., Infectious Disease Screening NAT Volume Forecast
- U.K., NAT Market Forecast By Major Application
- U.K., Infectious Disease Screening NAT Reagent Market Forecast by Test
- U.K., NAT Market by Major Supplier
- Summary Table U.S.A., NAT Volume And Sales Forecast by Major Application
- U.S.A., Laboratories Performing DNA Sequencing by Market Segment
- U.S.A., NAT Market, Potential Laboratory Universe by Market Segment
- U.S.A., NAT Volume Forecast By Major Application
- U.S.A., Major Infectious Disease NAT Volume Forecast
- U.S.A., Infectious Disease Screening NAT Volume by Test Forecast
- U.S.A., NAT Market Forecast By Major Application
- U.S.A., Infectious Disease Screening NAT Reagent Market Forecast by Test
- U.S.A., NAT Market by Major Supplier
- U.S.A., HIV/Hepatitis C NAT Market By Major Supplier
- U.S.A., West Nile Virus NAT Market By Major Supplier
|
